Intergenotypic variation of nitric oxide and inflammatory markers in preeclampsia: A pilot study in a North Indian population

Human Immunology

Volumn 72, Issue 5, 2011, Pages 436-439

  Sharma, Deepika ^a   Singh, Archana ^b   Trivedi, Shubha Sagar ^a   Bhattacharjee, Jayashree ^a  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

^b UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

Cytokines; Immunology; India; Polymorphism; Preeclampsia

Indexed keywords

CYTOKINE; DNA; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAMMA INTERFERON; INTERLEUKIN 2; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD GAS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DNA POLYMORPHISM; ENDOTHELIAL DYSFUNCTION; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; PILOT STUDY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BIOLOGICAL MARKERS; CYTOKINES; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; INFLAMMATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PILOT PROJECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY;

EID: 79954589568     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.02.007     Document Type: Article

References (32)

1. Lyall F., Greer I.A. Preeclampsia: A multifaceted vascular disorder of pregnancy. J Hypertens 1994, 12:1339-1345.
2. Lyall F., Greer I.A., Boswell F., Macara L.M., Walker J.J., Kingdom J.C. The cell adhesion molecule, VCAM-1, is selectively elevated in serum in preeclampsia: Does this indicate the mechanism of leucocyte activation?. Br J Obstet Gynaecol 1994, 101:173-174.
3. Jonsson Y., Ruber M., Matthiesen L., et al. Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J Reprod Immunol 2006, 70:83-91.
4. Olusi S.O., Diejomaoh M., Omu A., Abdulaziz A., Prabha K., George S., et al. Interleukins in preeclampsia. Ann Saudi Med 2000, 20:4.
5. Rodie V.A., Freeman D.J., Sattar N., Greer I.A. Preeclampsia and cardiovascular disease: Metabolic syndrome of pregnancy?. Atherosclerosis 2004, 175:189-202.
6. Redman C.W.G., Sacks G.P., Sargent I.L. Preeclampsia: An excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999, 180:499-506.
7. Savvidou M.D., Vallance P.J., Nicolaides K.H., Hingorani A.D. Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy. Hypertension 2001, 38:1289-1293.
8. Jeerooburkan N., Jones L.C., Bujac S., Cooper J.A., Miller G.J., Vallance P., et al. Genetic and environmental determinants of plasma nitrogen oxides and risk of ischaemic heart disease. Hypertension 2001, 38:1054-1061.
9. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
10. Blake G.J., Ridker P.M.J. Inflammatory biomarkers and cardiovascular risk prediction. J Intern Med 2002, 252:283-294.
11. Brown M.A., Lindheimer M.D., de Swiet M., Van Assche A., Moutquin J.M. The classification of hypertensive disorder of pregnancy (ISSHP). Hypertens Pregnancy 2001, 20:9-14.
12. Mathew G., Glenda J., Jack L. Quantitation of nitrite and nitrate in extra-cellular fluids. Methods Enzymol 1996, 268:237-246.
13. Bellard M., Oudet P., Chambon P. Isolation of high molecular weight DNA from mammalian cells. Eur J Biochem 1973, 36:32-38.
14. Hibi K., Ishigami T.Kouichi Tamura, et al. Endothelial nitric oxide synthase Gene Polymorphism and acute myocardial infarction. Hypertension 1998, 32:521-526.
15. Khetsuriani T., Makharashvili P., Mamamtavrishvili I., Khurtsidze E. Changes in Placental NO Levels during Physiological Pregnancy and Pregnancy Complicated with Eclampsia. Ann Biomed Res Educ 2004, 4:3.
16. Norris L.A., Higgins J.R., Darling M.R., Walshe J.J., Bonnar J. Nitric oxide in the uteroplacental, fetoplacental and peripheral circulations in pre-eclampsia. Obstet Gynecol 1999, 93. 958-6.
17. Yu C.K.H., Casas J.P., Savvidou M.D., Sahemey M.K., Nicolaides K.H., Hingorani A.D. Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: A case-control study and a meta-analysis. BMC Pregnancy Childbirth 2006, 6:1471-1477.
18. Landau R., Xie H.G., Dishy V., Wood A.J., Stein C.M., Smiley R.M., et al. No association of the Asp298 variant of the endothelial nitric oxide synthase gene with pre-eclampsia. Am J Hypertens 2004, 17:391-394.
19. Serrano N.C., Casas J.P., Diaz L.A., et al. Endothelial nitric oxide synthase genotype and risk of pre-eclampsia: A multi-centre case-control study. Hypertension 2004, 44:702-707.
20. Saito S., Sakai M., Sasaki Y., Tanebe K., Tsuda H., Michimata T., et al. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol 1999, 117:550-555.
21. Conrad K.P., Miles T.M., Benyo D.F. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998, 40:102-111.
22. Tinsley J.H., Chiasson V.L., South S., Mahajan A., Mitchell B.M. Immunosuppression improves blood pressure and endothelial function in a rat model of pregnancy-induced hypertension. Am J Hypertens 2009, 22:1107-1114.
23. Yang J., Xu W., Xia Q. Endothelial dysfunction and injury of placental and umbilical vessels in pregnancy-induced hypertension is associated with tumor necrosis factor. Zhonghua Fu Chan Ke Za Ahi 2000, 35:279-289.
24. Verccrysse L., Haness S.M., Johnson P.M., Keith J.C., Van Assche F.A. Immunolocalisation of tumor necrosis factor-alpha (TNF-alpha) in the placental bed of normotensive and hypertensive human pregnancies. Placenta 1998, 19:231-239.
25. Clark D.A., Chaouat G., Arck P.C., Mittruecker H.W., Levy G.A. Cytokinedependent abortion in CBAxDBA/2 mice is mediated by the procoagulant fgl2 prothombinase. J Immunol 1998, 160:545-549.
26. Bennett W.A., Lagoo-Deenadayalan S., Brackin M.N., Hale E., Cowan B.D. Cytokine expression by models of human trophoblast as assessed by a semiquantitative reverse transcription-polymerase chain reaction technique. Am J Reprod Immunol 1996, 36:285-294.
27. Barnes P.J., Liew F.Y. Nitric oxide and asthmatic inflammation. Immunol Today 1995, 16:128-130.
28. Kato N., Sugiyama T., Morita H., Nabika T., Kurihara H., Yamori Y., et al. Lack of evidence for association between the eNOS gene and hypertension. Hypertension 1999, 33:933-936.
29. Hingorani A.D. Endothelial nitric oxide synthase polymorphisms and hypertension. Curr Hypertens Rep 2003, 5:19-25.
30. Savvidou M.D., Vallance P.J., Nicolaides K.H., Hingorani A.D. Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy. Hypertension 2001, 38:1289-1293.
31. Yan G., You B., Chen S.P., Liao J.K., Sun J. Tumor necrosis factor-alpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha. Circ Res 2008, 103:591-597.
32. Rockey D.C., Chung J.J. Regulation of inducible nitric oxide synthase in hepatic sinusoidal endothelial cells. Am J Physiol Gastrointest Liver Physiol 1996, 271:G260-G267.